Revolution Medicines reports phase 1 data for lung cancer drug - Stock Watch Index

Revolution Medicines reports phase 1 data for lung cancer drug

April 19, 2026

Revolution Medicines reports phase 1 data for lung cancer drug

Search

RECENT PRESS RELEASES

AWS Launches Amazon Bio Discovery to Speed AI Drug Development

SWI Editorial Staff2026-04-19T13:53:21-07:00April 19, 2026|

BTC/USD: Bitcoin Price Dips On Flight From Speculative Asset

SWI Editorial Staff2026-04-19T13:37:19-07:00April 19, 2026|

Egypt to add 2,500 MW of renewable energy capacity by 2026

SWI Editorial Staff2026-04-19T13:25:00-07:00April 19, 2026|

Tesla Has Reclaimed Its Spot as the Leading Global EV Manufacturer, but Is the Stock a Buy?

SWI Editorial Staff2026-04-19T13:21:00-07:00April 19, 2026|

Japan Renewable Energy Certificate Market Outlook (2026-2032)- Policy Landscape, Demand Drivers & Strategic Op

SWI Editorial Staff2026-04-19T13:04:18-07:00April 19, 2026|

Investors brace for renewed volatility after this weekend’s Iran developments

SWI Editorial Staff2026-04-19T12:49:00-07:00April 19, 2026|

Related Post